Intrexon slips after earnings report

Synthetic biology company Intrexon Corp. (NYSE:XON) sank $3.66 (20%) to $14.98 on Friday after it reported 1Q18 EPS and revenues that missed consensus estimates.

Intrexon reported a loss per share of $0.33 on revenues of $43.8 million. Analysts expected a loss of $0.19 on revenues of $60.4 million...